- MedAdvisor (MDR) has adjusted the price for its capital raise
- Investors will now be able to grab the health stock’s shares at 38 cents, which is 7 cents cheaper than the initial price
- Under the capital raise, the company is aiming to raise $45 million, with a minimum target of $35 million
- The purchase will accelerate MedAdvisor’s U.S. presence by using Adheris’ existing pharmacy integrations
- MedAdvisor’s and Adheris technology will integrate to create programs that can positively influence patient behavior from point of initial prescribing to the pharmacy
- Company shares last traded for 40 cents on October 30
